Welcome to LookChem.com Sign In|Join Free

CAS

  • or

154422-95-4

Post Buying Request

154422-95-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

154422-95-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 154422-95-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,4,4,2 and 2 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 154422-95:
(8*1)+(7*5)+(6*4)+(5*4)+(4*2)+(3*2)+(2*9)+(1*5)=124
124 % 10 = 4
So 154422-95-4 is a valid CAS Registry Number.

154422-95-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,2,3,6-tetrahydro-4-(2-methoxyphenyl)pyridine

1.2 Other means of identification

Product number -
Other names 4-(2-methoxyphenyl)-1,2,3,6-tetrahydropyridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:154422-95-4 SDS

154422-95-4Relevant articles and documents

Successful reduction of off-target hERG toxicity by structural modification of a T-type calcium channel blocker

Choi, Yeon Jae,Seo, Jae Hong,Shin, Kye Jung

, p. 880 - 883 (2014/02/14)

To obtain an optimized T-type calcium channel blocker with reduced off-target hERG toxicity, we modified the structure of the original compound by introducing a zwitterion and reducing the basicity of the nitrogen. Among the structurally modified compound

Tetrahydrobenzindole compounds

-

, (2010/02/05)

A compound of formula (I) for use in the treatment or prevention of mental diseases A is N, CH, C having a double bond or CR5; each of B and Z is independently N, CH or CR1, with the proviso that A is N when B and/or Z is N; R1, R2, R3, R4and R5and n are as defined in the specification.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 154422-95-4